Compounds > arimoclomol
Page last updated: 2024-09-05

arimoclomol and Lymphoma, B-Cell, Marginal Zone

arimoclomol has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dilzer, K1

Other Studies

1 other study(ies) available for arimoclomol and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Upcoming market catalysts in Q1 2021.
    Nature reviews. Drug discovery, 2021, Volume: 20, Issue:1

    Topics: Drug Approval; Dystrophin; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxylamines; Lymphoma, B-Cell, Marginal Zone; Muscular Dystrophy, Duchenne; Niemann-Pick Diseases; United States; United States Food and Drug Administration

2021